APA (7th ed.) Citation

T, B., U, O., S, O., O, K., S, Y., S, K., . . . N, T. (2025). Triple-Negative Apocrine Carcinoma: Largest Cohort Highlights Unique Biology and Survival Advantage. Journal of clinical medicine, 14(19), . https://doi.org/10.3390/jcm14197103

Chicago Style (17th ed.) Citation

T, Basoglu, et al. "Triple-Negative Apocrine Carcinoma: Largest Cohort Highlights Unique Biology and Survival Advantage." Journal of Clinical Medicine 14, no. 19 (2025). https://doi.org/10.3390/jcm14197103.

MLA (9th ed.) Citation

T, Basoglu, et al. "Triple-Negative Apocrine Carcinoma: Largest Cohort Highlights Unique Biology and Survival Advantage." Journal of Clinical Medicine, vol. 14, no. 19, 2025, https://doi.org/10.3390/jcm14197103.